Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,029 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Disappearing hyperdense middle cerebral artery sign in ischaemic stroke patients treated with intravenous thrombolysis: clinical course and prognostic significance.
Kharitonova T, Thorén M, Ahmed N, Wardlaw JM, von Kummer R, Thomassen L, Wahlgren N; SITS investigators. Kharitonova T, et al. Among authors: wardlaw jm. J Neurol Neurosurg Psychiatry. 2009 Mar;80(3):273-8. doi: 10.1136/jnnp.2008.150185. Epub 2008 Oct 17. J Neurol Neurosurg Psychiatry. 2009. PMID: 18931005
Hyperdense middle cerebral artery sign on admission CT scan--prognostic significance for ischaemic stroke patients treated with intravenous thrombolysis in the safe implementation of thrombolysis in Stroke International Stroke Thrombolysis Register.
Kharitonova T, Ahmed N, Thorén M, Wardlaw JM, von Kummer R, Glahn J, Wahlgren N. Kharitonova T, et al. Among authors: wardlaw jm. Cerebrovasc Dis. 2009;27(1):51-9. doi: 10.1159/000172634. Epub 2008 Nov 15. Cerebrovasc Dis. 2009. PMID: 19018138
The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial.
IST-3 collaborative group; Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G, Innes K, Venables G, Czlonkowska A, Kobayashi A, Ricci S, Murray V, Berge E, Slot KB, Hankey GJ, Correia M, Peeters A, Matz K, Lyrer P, Gubitz G, Phillips SJ, Arauz A. IST-3 collaborative group, et al. Among authors: wardlaw jm. Lancet. 2012 Jun 23;379(9834):2352-63. doi: 10.1016/S0140-6736(12)60768-5. Epub 2012 May 23. Lancet. 2012. PMID: 22632908 Free PMC article. Clinical Trial.
Hyperintense vessels on acute stroke fluid-attenuated inversion recovery imaging: associations with clinical and other MRI findings.
Cheng B, Ebinger M, Kufner A, Köhrmann M, Wu O, Kang DW, Liebeskind D, Tourdias T, Singer OC, Christensen S, Warach S, Luby M, Fiebach JB, Fiehler J, Gerloff C, Thomalla G; Stroke Imaging Repository (STIR) Investigators. Cheng B, et al. Stroke. 2012 Nov;43(11):2957-61. doi: 10.1161/STROKEAHA.112.658906. Epub 2012 Aug 28. Stroke. 2012. PMID: 22933582 Free PMC article.
Details of a prospective protocol for a collaborative meta-analysis of individual participant data from all randomized trials of intravenous rt-PA vs. control: statistical analysis plan for the Stroke Thrombolysis Trialists' Collaborative meta-analysis.
Stroke Thrombolysis Trialists' Collaborative Group. Stroke Thrombolysis Trialists' Collaborative Group. Int J Stroke. 2013 Jun;8(4):278-83. doi: 10.1111/ijs.12040. Epub 2013 May 3. Int J Stroke. 2013. PMID: 23639145 Free PMC article.
EuroHYP-1: European multicenter, randomized, phase III clinical trial of therapeutic hypothermia plus best medical treatment vs. best medical treatment alone for acute ischemic stroke.
van der Worp HB, Macleod MR, Bath PM, Demotes J, Durand-Zaleski I, Gebhardt B, Gluud C, Kollmar R, Krieger DW, Lees KR, Molina C, Montaner J, Roine RO, Petersson J, Staykov D, Szabo I, Wardlaw JM, Schwab S; EuroHYP-1 investigators. van der Worp HB, et al. Among authors: wardlaw jm. Int J Stroke. 2014 Jul;9(5):642-5. doi: 10.1111/ijs.12294. Epub 2014 May 15. Int J Stroke. 2014. PMID: 24828363 Clinical Trial.
1,029 results